articleThe LancetJul 24, 2024Closed access

Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

George Washington University · University Hospital Augsburg · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

117
total citations
FWCI
56.57
Percentile
100%
References
40
Citations per year

Authors

25

Topics & keywords

Keywords
  • Arcadia
  • Medicine
  • Atopic dermatitis
  • Concomitant
  • Dermatology
  • Double blind
  • Randomized controlled trial
  • Pediatrics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding